Univest Securities, LLC Announces Closing of $4 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)

Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $4 million for its client Haoxi Health Technology Ltd (NASDAQ: HAO) (the "Company"), a Beijing-headquartered online marketing solution provider in China, specializing in serving healthcare industry advertiser clients. Under the terms of the securities purchase agreement, the Company has agreed to sell to certain investors an aggregate of approximately $4 million of the Company's securities, including 10,000,000 Class A ordinary shares (the "Shares") (or pre-funded warrants in lieu thereof), at an offering price of $0.40 per share in the Offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.33 per share. The aggregate gross proceeds to the Company were $4 million. Univest Securities, LLC acted as the sole placement agent. The registered direct offering was made pursuant to a shelf registration statement on Form F-3 (File No. 333-287686) previously filed by the Company and declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on June 13, 2025. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering were filed with the SEC and are available on the SEC's website located at www.sec.gov . Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, by contacting Univest Securities, LLC at info@u...